Recent Headlines
Two Leading Biotech Publications Report on Advaxis’ Listeria Platform Technology
Advaxis’ John Rothman Recognized as one of 20 Notable People in R&D - March 16, 2007 - Advaxis
Name Change: AnaSpec’s EnzoLyte is now SensoLyte™
AnaSpec, a worldwide provider of integrated proteomics solutions, announced today that the name of their flagship line of high-performance assay kits has been changed from EnzoLyte to SensoLyte™. AnaSpec sales & marketing manager, Violeta Rajkovska, MBA, noted, “The new name... - March 14, 2007 - AnaSpec, EGT Group
Xcelience Employs "CFS1200 Capsule Filling and Sealing Machine"
Xcelience's implementation of the CFS1200 will allow its formulation scientists the opportunity to accelerate the drug development timeframe. - March 13, 2007 - Xcelience, LLC
Xcelience Completes Successful QP Audit of Production Facility for European Market
Xcelience achives its third successful audit. - March 09, 2007 - Xcelience, LLC
Xcelience Debuts its Innovative and Interactive Forum: XpertXchange™
XpertXchange will initiate dialogue between Xcelience scientists and drug development professionals. - March 02, 2007 - Xcelience, LLC
Creating New Life Forms that May Help Eradicate Cancer Affecting Women
Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to fighting cancer: Engaging the immune system to attack cancer in the same the way it would a flu vaccine, by... - February 27, 2007 - Advaxis
Xcelience Launches Drug Development Consulting Service
The launch of Xpert Consulting will provide supplemental services to assist clients. - January 17, 2007 - Xcelience, LLC
ASCB Poster Presents Immunocapture Techniques for Improved MMP Assay
At the annual conference of the American Society for Cell Biology, AnaSpec presented a technical poster documenting improved technology for MMP detection assays. In a previous poster, AnaSpec documented the use of highly sensitive FRET-peptide substrates for MMP detection. The latest poster... - December 19, 2006 - AnaSpec, EGT Group
Fluorinated Building Blocks Produce Molecules with Enhanced Physiological Activities
The substitution of the fluorine in place of hydrogen in building blocks, such as amino acids, has produced molecules with enhanced physiological activities (1-2). Some of these are antibacterial, antihypertensive and antitumoral (3). One reason for the enhanced activity is that fluorine forms a... - December 12, 2006 - AnaSpec, EGT Group
Swiss Medica to Pursue Military and International Contracts with the Appointment of Christensen Co. as Strategic Business Advisors
Swiss Medica, Inc. (OTCBB: SWME) announced today its intention to pursue military and international contracts with the appointment of Mr. Chad Christensen, Managing Director of Christensen Co., as Strategic Business Advisor. With a distinguished career in international banking, and advisor to... - July 30, 2006 - SwissMedica Support Group
AnaSpec Introduces New Line of Reagents and Kits for Study of Protein Phosphorylation
AnaSpec, a leading provider of integrated proteomics solutions, has introduced an extensive new line of reagents and kits for the study of protein phosphorylation. Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the... - June 06, 2006 - AnaSpec, EGT Group
WellAware™ Error-Free Light Guided Manual Pipetting System is Now Application Based
BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.
Cactus Botanics Increases the Production Capability of Policosanol
Cactus Botanics Limited, in cooperation with its Chinese manufacturing operations, has completed expansion of its production capabilities for Policosanol (Octacosanol 65%). - November 12, 2005 - Cactus Botanics Limited
Cactus Botanics Introduces Sesamin 90%
Cactus Botanics, a leading raw material supplier, announces the completion of development and introduction to the market of Sesamin 90% HPLC, currently the only Chinese supply of this level. - November 07, 2005 - Cactus Botanics Limited
TimTec 10-year Anniversary
TimTec Inc. is expressing customer and business partner appreciation as the company marks 10-years anniversary on the market of early drug-discovery. - October 17, 2005 - TimTec Corporation
Sigma-Aldrich Introduces the MyriaScreen Diversity Collection for Drug Discovery
Sigma-Aldrich (NASDAQ:SIAL) is pleased to announce the availability of the MyriaScreen Diversity Collection of drug-like screening compounds. The collection, produced in collaboration with TimTec Inc. (http://www.timtec.net), is the result of careful evaluation, filtering, and refinement of selections from each of our screening compound collections. - September 23, 2005 - TimTec Corporation
Cactus Botanics Leads in Drafting Quality Standards for Fucoidan Content
Cactus Botanics offers three specifications of Brown Seaweed with active ingredient Fucoidan and leads in drafting quality standards for assay of Fucoidan content. - August 29, 2005 - Cactus Botanics Limited